Alf Meem Yaa for Medical Supplies and Equipment (9527) Stock Overview
Engages in the wholesale and retail trade of medical supplies for the aesthetic market in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
9527 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Alf Meem Yaa for Medical Supplies and Equipment Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س108.60 |
| 52 Week High | ر.س149.80 |
| 52 Week Low | ر.س91.00 |
| Beta | -0.050 |
| 1 Month Change | 8.06% |
| 3 Month Change | -2.86% |
| 1 Year Change | -7.81% |
| 3 Year Change | 197.13% |
| 5 Year Change | n/a |
| Change since IPO | 67.08% |
Recent News & Updates
Here's Why We Think Alf Meem Yaa for Medical Supplies and Equipment (TADAWUL:9527) Might Deserve Your Attention Today
Jan 15
Alf Meem Yaa for Medical Supplies and Equipment Company's (TADAWUL:9527) Subdued P/E Might Signal An Opportunity
Jun 27Recent updates
Here's Why We Think Alf Meem Yaa for Medical Supplies and Equipment (TADAWUL:9527) Might Deserve Your Attention Today
Jan 15Alf Meem Yaa for Medical Supplies and Equipment Company's (TADAWUL:9527) Subdued P/E Might Signal An Opportunity
Jun 27Alf Meem Yaa for Medical Supplies and Equipment (TADAWUL:9527) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 06Alf Meem Yaa for Medical Supplies and Equipment Company (TADAWUL:9527) Investors Are Less Pessimistic Than Expected
Feb 28Here's Why Alf Meem Yaa for Medical Supplies and Equipment (TADAWUL:9527) Has Caught The Eye Of Investors
Dec 10Alf Meem Yaa for Medical Supplies and Equipment Company's (TADAWUL:9527) Price Is Right But Growth Is Lacking After Shares Rocket 33%
Nov 08Alf Meem Yaa for Medical Supplies and Equipment (TADAWUL:9527) Might Be Having Difficulty Using Its Capital Effectively
Nov 06Shareholder Returns
| 9527 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | 3.4% | 2.9% | 2.1% |
| 1Y | -7.8% | -19.2% | -10.5% |
Return vs Industry: 9527 exceeded the SA Healthcare industry which returned -19.2% over the past year.
Return vs Market: 9527 exceeded the SA Market which returned -10.5% over the past year.
Price Volatility
| 9527 volatility | |
|---|---|
| 9527 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in SA Market | 7.0% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 9527 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 9527's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Abd Ahmed | ame.med.sa |
Alf Meem Yaa for Medical Supplies and Equipment Company engages in the wholesale and retail trade of medical supplies for the aesthetic market in the Kingdom of Saudi Arabia. The company offers Teoxane, a range of injectable hyaluronic acid-based dermal fillers designed to treat wrinkles; Deka medical laser systems and therapies; Magellan, an autologous concentration system that delivers concentrated platelets and cells at the point of care; and Euromi medical, dermatological, and aesthetic surgery equipment. It also provides perfumes, cosmetics, orthotic devices, decorative soaps, incense, veterinary medicines, and medical equipment.
Alf Meem Yaa for Medical Supplies and Equipment Company Fundamentals Summary
| 9527 fundamental statistics | |
|---|---|
| Market cap | ر.س760.20m |
| Earnings (TTM) | ر.س46.71m |
| Revenue (TTM) | ر.س276.37m |
Is 9527 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9527 income statement (TTM) | |
|---|---|
| Revenue | ر.س276.37m |
| Cost of Revenue | ر.س162.14m |
| Gross Profit | ر.س114.23m |
| Other Expenses | ر.س67.52m |
| Earnings | ر.س46.71m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.67 |
| Gross Margin | 41.33% |
| Net Profit Margin | 16.90% |
| Debt/Equity Ratio | 27.1% |
How did 9527 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/23 10:26 |
| End of Day Share Price | 2026/01/22 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alf Meem Yaa for Medical Supplies and Equipment Company is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marina Mikhail | CI Capital Research |